SLE

Patrick DalyITP | August 28, 2023
Researchers, led by Soo Min Ahn, examined patients with primary immune thrombocytopenia (ITP) who later developed ...
Read More
Patrick DalyITP | August 28, 2023
Researchers, led by Yuqing Song, sought to uncover potential risk factors driving progression of immune thrombocytopenia ...
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
The debate discussed benefits and drawbacks of these two agents. See why Dr. Michelle Petri argues in favor of belimumab.
Kaitlyn D’OnofrioCOVID-19 | April 6, 2023
Patients with chronic rheumatic diseases (CRD) had much lower seroprevalence of SARS-CoV-2 antibodies compared to blood ...
Kaitlyn D’OnofrioRheumatology | May 21, 2021
Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to ...
Kaitlyn D’OnofrioRheumatology | April 12, 2023
A study identified factors predictive of preterm birth in pregnant women with systemic lupus erythematosus (SLE), ...
Kaitlyn D’OnofrioThrombosis | September 6, 2023
Patients with systemic lupus erythematosus (SLE) taking hydroxychloroquine may also benefit from improved vascular ...
Kaitlyn D’OnofrioLung Cancer | October 27, 2023
Patients with autoimmune diseases—including rheumatoid arthritis (RA)—do not have poorer lung cancer survival ...
Kaitlyn D’OnofrioRheumatology | December 18, 2020
Can Pre-exposure to Hydroxychloroquine Prevent COVID-19 in Patients with RA and SLE? ...
Kaitlyn D’OnofrioCOVID-19 | April 7, 2023
At the onset of the COVID-19 pandemic, hydroxychloroquine became a hot topic as a possible treatment for the virus. ...
Kaitlyn D’OnofrioRheumatology | November 20, 2020
Interview: Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE ...
Kaitlyn D’OnofrioACR 2020 Conference | August 1, 2023
During the American College of Rheumatology (ACR) Convergence 2020, several presentations discussed data on the use of ...
Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023
The COVID-19 pandemic impacted virtually all areas of health care, whether it be access to medication, conversions to ...
Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023
Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, has been the subject of several clinical ...
Kaitlyn D’OnofrioRheumatology | August 21, 2020
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about why ...
Kaitlyn D’OnofrioRheumatology | August 21, 2020
Many systemic lupus erythematosus (SLE) patients take hydroxychloroquine to help manage their disease. Benefits of the ...
Kaitlyn D’OnofrioRheumatology | May 15, 2020
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about more ...
Kaitlyn D’OnofrioRheumatology | September 12, 2023
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an ...
Kaitlyn D’OnofrioCOVID-19 | April 6, 2023
Rumors that lupus patients are protected from COVID-19 because many of them take hydroxychloroquine are just ...
Kaitlyn D’OnofrioCOVID-19 | April 6, 2023
Nationwide shortages of hydroxychloroquine (Plaquenil) and chloroquine (Aralen) have raised concern among patients who ...
Advertisement
Advertisement
Latest News

February 26, 2024